The endothelial receptor of the angiotensin 2 converting enzyme (ACE2) responsible for SARS-CoV-2 invasion in human cells has reduced expression in patients with diabetes, possibly due to glycosylation. This evidence concerns the gene ACE2 and diabetes mellitus.